Advancing Strategies to Optimize the PerIopeRativE Management of PostOperative Nausea and Vomiting (ASPIRE-PONV) Trial

Last updated: January 9, 2026
Sponsor: Vanderbilt University Medical Center
Overall Status: Active - Recruiting

Phase

N/A

Condition

Post-operative Nausea And Vomiting

Treatment

AW-D Clinical Decision Support Tool

Clinical Study ID

NCT07152249
250773
  • Ages > 18
  • All Genders

Study Summary

The goal of this prospective, unblinded, pragmatic and repeated crossover trial is to learn if clinical decision support alerts will impact postoperative nausea and vomiting (PONV) prophylaxis and reduce PONV rates in adult patients who have planned surgery with general anesthesia. The main aim is to improve PONV, establishing a scalable Clinical Decision Support (CDS) Tool for personalized PONV prevention.

The primary hypothesis is that, compared with standard care, the Anesthesia Workflow-Driven Clinical Decision Support Tool for Personalized PONV Prevention will be associated with a significant improvement in the rate of appropriate administration of PONV prophylaxis and a significant decrease in the incidence of PONV.

This study will evaluate a new clinical decision support (CDS) tool designed to improve how and when PONV prevention strategies are used. Unlike traditional tools that provide generic, one-time alerts, this new system is integrated into the electronic health record (EHR) and delivers timely, targeted reminders to anesthesia providers at key moments during a patient's surgical care-such as before surgery begins, after anesthesia is given, and before the patient wakes up. These alerts are based on each patient's individual risk for PONV and are intended to support, not replace, clinical judgment. The study will use a crossover design over 12 months, alternating between periods when the tool is active and when it is not. The goal is to determine whether this time-sensitive, workflow-integrated tool can lead to better adherence to best practices and improved patient outcomes.

Eligibility Criteria

Inclusion

Adult Inclusion Criteria

  • Age ≥ 18 years

  • Planned surgery with general anesthesia with endotracheal intubation or laryngeal mask airway

  • Meet zero or more risk factors for PONV ( history of motion sickness or postoperative nausea and vomiting, non-smoker, female sex, duration of inhalation anesthesia greater than 1 hour, undergoing high risk surgical procedure (cholecystectomy, laparoscopy, gynecologic), and perioperative opioid use)

Adult Exclusion Criteria

  • ASA 6 including organ procurement,

  • Patients anticipated to be transferred directly to the intensive care unit intubated,

  • Procedure types:

  • Electroconvulsive therapy,

  • Intubation only cases,

  • labor epidurals,

  • transesophageal echocardiography (TEE)/cardioversion,

  • surgery duration < 30 minutes.

Operating Room Anaesthesia Provider Inclusion Criteria

Any operating room anaesthesia provider of eligible patients will be included.

Study Design

Total Participants: 19480
Treatment Group(s): 1
Primary Treatment: AW-D Clinical Decision Support Tool
Phase:
Study Start date:
September 03, 2025
Estimated Completion Date:
September 30, 2026

Connect with a study center

  • Vanderbilt University Medical Center

    Nashville 4644585, Tennessee 4662168 37212
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.